Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Depression

  Free Subscription


Articles published in Can J Psychiatry

Retrieve available abstracts of 48 articles:
HTML format



Single Articles


    April 2024
  1. WANG T, Gao C, Li J, Li L, et al
    Prediction of Early Antidepressant Efficacy in Patients with Major Depressive Disorder Based on Multidimensional Features of rs-fMRI and P11 Gene DNA Methylation: Prediction de l'efficacite precoce d'un antidepresseur chez des patients souffrant du tr
    Can J Psychiatry. 2024;69:264-274.
    PubMed     Abstract available


    February 2024
  2. JALALI S, Liu L, Wang J, Kennedy SH, et al
    Factors Associated with Transition to Serious Mental Illness.
    Can J Psychiatry. 2024;69:79-88.
    PubMed     Abstract available


  3. LAPOSA JM, Cameron D, Corace K, Quick N, et al
    A Rapid Access Brief Psychotherapy Intervention to Respond to Healthcare Workers in Ontario Whose Mental Health was Negatively Impacted During the COVID-19 Pandemic.
    Can J Psychiatry. 2024;69:89-99.
    PubMed     Abstract available


    December 2023
  4. LAI KSP, Waxman R, Blumberger DM, Giacobbe P, et al
    Competencies for Repetitive Transcranial Magnetic Stimulation in Postgraduate Medical Education: Expert Consensus Using a Modified Delphi Process.
    Can J Psychiatry. 2023;68:916-924.
    PubMed     Abstract available


    November 2023
  5. KHAN I, Chawla N
    Comments on "A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial".
    Can J Psychiatry. 2023 Nov 22:7067437231216175. doi: 10.1177/07067437231216175.
    PubMed    


  6. PINTO JV, Crippa JAS, Cereser KM, Vianna-Sulzbach MF, et al
    Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study.
    Can J Psychiatry. 2023 Nov 3:7067437231209650. doi: 10.1177/07067437231209650.
    PubMed     Abstract available


    October 2023
  7. ISLAM F, Magarbeh L, Elsheikh SSM, Kloiber S, et al
    Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A Canadian Biomarker Integration Network in Depression 1 (CAN-BIND 1) Study.
    Can J Psychiatry. 2023 Oct 5:7067437231203433. doi: 10.1177/07067437231203433.
    PubMed     Abstract available


    September 2023
  8. ANDREWS KL, Jamshidi L, Nisbet J, Brunet A, et al
    Potentially Psychologically Traumatic Event Exposure Histories of new Royal Canadian Mounted Police Cadets.
    Can J Psychiatry. 2023;68:663-681.
    PubMed     Abstract available


    August 2023
  9. BASTIEN G, McAnulty C, Ledjiar O, Socias ME, et al
    Effects of Buprenorphine/Naloxone and Methadone on Depressive Symptoms in People with Prescription Opioid Use Disorder: A Pragmatic Randomised Controlled Trial.
    Can J Psychiatry. 2023;68:572-585.
    PubMed     Abstract available


    May 2023
  10. TOURJMAN SV, Buck G, Jutras-Aswad D, Khullar A, et al
    Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: A Systematic Review and Recommendations of Cannabis use in Bipolar Disorder and Major Depressive Disorder.
    Can J Psychiatry. 2023;68:299-311.
    PubMed     Abstract available


    April 2023
  11. ADHIKARI K, Racine N, Hetherington E, McDonald S, et al
    Women's Mental Health up to Eight Years after Childbirth and Associated Risk Factors: Longitudinal Findings from the All Our Families Cohort in Canada.
    Can J Psychiatry. 2023;68:269-282.
    PubMed     Abstract available


  12. WOOD-ROSS C, Tran T, Milanovic M, Jokic R, et al
    Neurocognition and Depressive Symptoms have Unique Pathways to Predicting Different Domains of Functioning in Major Depressive Disorder.
    Can J Psychiatry. 2023;68:241-248.
    PubMed     Abstract available


    February 2023
  13. ISHRAT HUSAIN M, Rodie DJ, Perivolaris A, Sanches M, et al
    A Collaborative-Care Telephone-Based Intervention for Depression, Anxiety, and at-Risk Drinking in Primary Care: The PARTNERs Randomized Clinical Trial.
    Can J Psychiatry. 2023 Feb 28:7067437231156243. doi: 10.1177/07067437231156243.
    PubMed     Abstract available


  14. HARKNESS KL, Chakrabarty T, Rizvi SJ, Mazurka R, et al
    The Differential Relation of Emotional, Physical, and Sexual Abuse Histories to Antidepressant Treatment Remission and Persistence of Anhedonia in Major Depression: A CAN-BIND-1 Report.
    Can J Psychiatry. 2023 Feb 13:7067437231156255. doi: 10.1177/07067437231156255.
    PubMed     Abstract available


    January 2023
  15. GREEN JE, Berk M, Mohebbi M, Loughman A, et al
    Feasibility, Acceptability, and Safety of Faecal Microbiota Transplantation in the Treatment of Major Depressive Disorder: A Pilot Randomized Controlled Trial.
    Can J Psychiatry. 2023 Jan 13:7067437221150508. doi: 10.1177/07067437221150508.
    PubMed     Abstract available


  16. ROSENBLAT JD, Husain MI, Lee Y, McIntyre RS, et al
    The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.
    Can J Psychiatry. 2023;68:5-21.
    PubMed     Abstract available


    November 2022
  17. SLOMP C, Morris E, Edwards L, Hoens AM, et al
    Pharmacogenomic Testing for Major Depression: A Qualitative Study of the Perceptions of People with Lived Experience and Professional Stakeholders.
    Can J Psychiatry. 2022 Nov 28:7067437221140383. doi: 10.1177/07067437221140383.
    PubMed     Abstract available


  18. KAHAWAGE P, Bullock B, Meyer D, Gottlieb J, et al
    Social Rhythm Disruption is Associated with Greater Depressive Symptoms in People with Mood Disorders: Findings from a Multinational Online Survey During COVID-19.
    Can J Psychiatry. 2022;67:831-840.
    PubMed     Abstract available


    August 2022
  19. THATIKONDA NS, Vinod P, Balachander S, Bhaskarpillai B, et al
    Efficacy of Repetitive Transcranial Magnetic Stimulation on Comorbid Anxiety and Depression Symptoms in Obsessive-Compulsive Disorder: A Meta-Analysis of Randomized Sham-Controlled Trials.
    Can J Psychiatry. 2022 Aug 22:7067437221121112. doi: 10.1177/07067437221121112.
    PubMed     Abstract available


    May 2022
  20. DO A, Li VW, Huang S, Michalak EE, et al
    Blue-Light Therapy for Seasonal and Non-Seasonal Depression: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
    Can J Psychiatry. 2022 May 6:7067437221097903. doi: 10.1177/07067437221097903.
    PubMed     Abstract available


  21. BONARDI O, Wang Y, Li K, Jiang X, et al
    Effects of COVID-19 Mental Health Interventions Among Children, Adolescents, and Adults Not Quarantined or Undergoing Treatment Due to COVID-19 Infection: A Systematic Review of Randomised Controlled Trials.
    Can J Psychiatry. 2022;67:336-350.
    PubMed     Abstract available


  22. GOEGAN SA, Hasey GM, King JP, Losier BJ, et al
    Naturalistic Study on the Effects of Electroconvulsive Therapy (ECT) on Depressive Symptoms.
    Can J Psychiatry. 2022;67:351-360.
    PubMed     Abstract available


    April 2022
  23. DIEP C, Bhat V, Wijeysundera DN, Clarke HA, et al
    The Association between Recent Cannabis Use and Suicidal Ideation in Adults: A Population-based Analysis of the NHANES from 2005 to 2018.
    Can J Psychiatry. 2022;67:259-267.
    PubMed     Abstract available


    March 2022
  24. VASILIADIS HM, Lamoureux-Lamarche C, Grenier S, Roberge P, et al
    Minimally Adequate Treatment for Depression and Anxiety Associated With Mortality in Primary Care Older Adults.
    Can J Psychiatry. 2022 Mar 7:7067437221082883. doi: 10.1177/07067437221082883.
    PubMed     Abstract available


  25. XI C, Liu Z, Zeng C, Tan W, et al
    The centrality of working memory networks in differentiating bipolar type I depression from unipolar depression: A task-fMRI study.
    Can J Psychiatry. 2022 Mar 4:7067437221078646. doi: 10.1177/07067437221078646.
    PubMed     Abstract available


    January 2022
  26. VAN LIESHOUT RJ, Layton H, Savoy CD, Haber E, et al
    Public Health Nurse-delivered Group Cognitive Behavioural Therapy for Postpartum Depression: A Randomized Controlled Trial.
    Can J Psychiatry. 2022 Jan 21:7067437221074426. doi: 10.1177/07067437221074426.
    PubMed     Abstract available


  27. BENOIT JRA, Dursun SM, Greiner R, Cao B, et al
    Using Machine Learning to Predict Remission in Patients With Major Depressive Disorder Treated With Desvenlafaxine.
    Can J Psychiatry. 2022;67:39-47.
    PubMed     Abstract available


    November 2021
  28. SAREEN J, Bolton SL, Mota N, Afifi TO, et al
    Lifetime Prevalence and Comorbidity of Mental Disorders in the Two-wave 2002-2018 Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey (CAFVMHS): Prevalence et Comorbidite de Duree de vie Des Troubles Mentaux Dans l'Enquete de Sui
    Can J Psychiatry. 2021;66:951-960.
    PubMed     Abstract available


  29. AFIFI TO, Sareen J, Taillieu T, Stewart-Tufescu A, et al
    Association of Child Maltreatment and Deployment-related Traumatic Experiences with Mental Disorders in Active Duty Service Members and Veterans of the Canadian Armed Forces: Association de la Maltraitance des Enfants et des Experiences Traumatisantes
    Can J Psychiatry. 2021;66:961-970.
    PubMed     Abstract available


    October 2021
  30. SARRIS J, Marx W, Ashton MM, Ng CH, et al
    Plant-based Medicines (Phytoceuticals) in the Treatment of Psychiatric Disorders: A Meta-review of Meta-analyses of Randomized Controlled Trials: Les medicaments a base de plantes (phytoceutiques) dans le traitement des troubles psychiatriques: une me
    Can J Psychiatry. 2021;66:849-862.
    PubMed     Abstract available


    September 2021
  31. BULLOCH A, Zulyniak S, Williams J, Bajgai J, et al
    Poor Mental Health during the COVD-19 Pandemic: Effect Modification by Age.
    Can J Psychiatry. 2021;66:827-829.
    PubMed    


  32. MCINERNEY SJ, Chakrabarty T, Maciukiewicz M, Frey BN, et al
    Cognition and Its Association with Psychosocial and Occupational Functioning during Treatment with Escitalopram in Patients with Major Depressive Disorder: A CAN-BIND-1 Report: La Cognition Et Son Association Avec Le Fonctionnement Psychosocial Et Pro
    Can J Psychiatry. 2021;66:798-806.
    PubMed     Abstract available


    June 2021
  33. WONG SMY, Hui CLM, Wong CSM, Suen YN, et al
    Mental Health Risks after Repeated Exposure to Multiple Stressful Events during Ongoing Social Unrest and Pandemic in Hong Kong: The Role of Rumination: Risques pour la sante mentale apres une exposition repetee a de multiples evenements stressants d'
    Can J Psychiatry. 2021;66:577-585.
    PubMed     Abstract available


  34. ZARATE CA JR
    Commentary on the Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder.
    Can J Psychiatry. 2021;66:537-539.
    PubMed    


    April 2021
  35. VAIDYAM AN, Linggonegoro D, Torous J
    Changes to the Psychiatric Chatbot Landscape: A Systematic Review of Conversational Agents in Serious Mental Illness: Changements du paysage psychiatrique des chatbots: une revue systematique des agents conversationnels dans la maladie mentale serieus
    Can J Psychiatry. 2021;66:339-348.
    PubMed     Abstract available


    March 2021
  36. MORTON E, Michalak EE, Levitt A, Levitan RD, et al
    Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial.
    Can J Psychiatry. 2021;66:289-297.
    PubMed     Abstract available


    February 2021
  37. SWAINSON J, McGirr A, Blier P, Brietzke E, et al
    The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Recommendations for the Use of Racemic Ketamine in Adults with Major Depressive Disorder: Recommandations Du Groupe De Travail Du Reseau Canadien Pour Les Traitements De L'humeur
    Can J Psychiatry. 2021;66:113-125.
    PubMed     Abstract available


  38. BHARGAV PH, Reddy PV, Govindaraj R, Gulati K, et al
    Impact of a Course of Add-on Supervised Yoga on Cortical Inhibition in Major Depressive Disorder: A Randomized Controlled Trial.
    Can J Psychiatry. 2021;66:179-181.
    PubMed    


  39. BARTOLI F, Bachi B, Calabrese A, Moretti F, et al
    Cannabidiol for Mood Disorders: A Call for More Research.
    Can J Psychiatry. 2021;66:182-183.
    PubMed    


    January 2021
  40. ENNS MW, Mota N, Afifi TO, Bolton SL, et al
    Course and Predictors of Major Depressive Disorder in the Canadian Armed Forces Members and Veterans Mental Health Follow-up Survey: Cours et Predicteurs du Trouble de Depression Majeure Dans l'Enquete de Suivi Sur la Sante Mentale Aupres Des Membres
    Can J Psychiatry. 2021 Jan 7:706743720984677. doi: 10.1177/0706743720984677.
    PubMed     Abstract available


  41. LEMIEUX R, Garon-Bissonnette J, Loiselle M, Martel E, et al

    Can J Psychiatry. 2021;66:34-42.
    PubMed     Abstract available


  42. SMITH PM, Oudyk J, Potter G, Mustard C, et al
    The Association between the Perceived Adequacy of Workplace Infection Control Procedures and Personal Protective Equipment with Mental Health Symptoms: A Cross-sectional Survey of Canadian Health-care Workers during the COVID-19 Pandemic: L'associatio
    Can J Psychiatry. 2021;66:17-24.
    PubMed     Abstract available


  43. MURRAY G, Gottlieb J, Swartz HA
    Maintaining Daily Routines to Stabilize Mood: Theory, Data, and Potential Intervention for Circadian Consequences of COVID-19.
    Can J Psychiatry. 2021;66:9-13.
    PubMed    


    November 2020
  44. LI A, Rosella LC, Kurdyak P, Wodchis WP, et al
    Depression as a Risk Factor for Physical Illness and Multimorbidity in a Cohort with No Prior Comorbidity: La Depression Comme Facteur de Risque de Maladie Physique et de Multimorbidite Dans Une Cohorte Sans Comorbidite Anterieure.
    Can J Psychiatry. 2020 Nov 26:706743720974832. doi: 10.1177/0706743720974832.
    PubMed     Abstract available


  45. BAHJI A, Ermacora D, Stephenson C, Hawken ER, et al
    Comparative Efficacy and Tolerability of Adjunctive Pharmacotherapies for Acute Bipolar Depression: A Systematic Review and Network Meta-analysis: Efficacite Et Tolerabilite Comparatives Des Pharmacotherapies D'appoint Pour La Depression Bipolaire Aig
    Can J Psychiatry. 2020 Nov 11:706743720970857. doi: 10.1177/0706743720970857.
    PubMed     Abstract available


    October 2020
  46. THOMBS BD, Levis B, Lyubenova A, Neupane D, et al
    Overestimation of Postpartum Depression Prevalence Based on a 5-item Version of the EPDS: Systematic Review and Individual Participant Data Meta-analysis.
    Can J Psychiatry. 2020 Oct 26:706743720934959. doi: 10.1177/0706743720934959.
    PubMed     Abstract available


  47. SCHMITZ N, Holley P, Meng X, Fish L, et al
    COVID-19 and Depressive Symptoms: A Community-based Study in Quebec, Canada.
    Can J Psychiatry. 2020;65:733-735.
    PubMed    


  48. ZHOU L, Xie RH, Yang X, Zhang S, et al
    Feasibility and Preliminary Results of Effectiveness of Social Media-based Intervention on the Psychological Well-being of Suspected COVID-19 Cases during Quarantine.
    Can J Psychiatry. 2020;65:736-738.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Depression is free of charge.